Date: April 14 - 17, 2025
Location: Rome, Italy

The promise of iPSC-derived allogeneic cell therapies is evident in their potential to transform treatment options. As an iPSC-based provider of integrated platforms for cell line development and GMP manufacturing, Cellistic is eager to discuss your specific project needs. We look forward to sharing updates on our innovative global capabilities, including our Allo Chassis™ off-the-shelf, immune-cloaked iPSC cell lines.

 

Our CEO, Gustavo Mahler, will contribute to the ARM conference program by presenting data on how Cellistic enhances accessibility to cell therapy by reducing cell line development and manufacturing costs while maintaining the highest quality standards. Don't miss Gustavo's presentation on April 16 at 11:15am in Salone dei Cavalieri, Section 2.

 

Tarran Pierfelice, Chief Commercial Officer, and Peter Jaehn, VP Cell Line Development Europe & APAC, will be on-site to connect and discuss how our cutting-edge solutions—integrating advanced technologies in gene editing, automation, and GMP manufacturing capabilities—can effectively support your cell therapy applications.

 

Attending Cell & Gene Meeting on the Med in Rome, Italy, April 14-17? Connect with Cellistic's experts in iPSC-based Allogeneic Cell Therapy.